44 related articles for article (PubMed ID: 38504533)
1. Inhibited corneal neovascularization in rabbits following corneal alkali burn by double-target interference for VEGF and HIF-1α.
Fu YC; Xin ZM
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355648
[TBL] [Abstract][Full Text] [Related]
2. Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.
Sun MM; Chan AM; Law SM; Duarte S; Diaz-Aguilar D; Wadehra M; Gordon LK
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):245-254. PubMed ID: 30646013
[TBL] [Abstract][Full Text] [Related]
3. Effect of a protein kinase B (Akt) inhibitor on the angiogenesis of HUVECs and corneal neovascularization.
Wang X; Wang P
Wien Klin Wochenschr; 2024 Mar; 136(5-6):154-162. PubMed ID: 37261487
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.
Qiu F; Shin Y; Chen D; Cheng R; Chen Q; Zhou K; Larrick JW; Mendelson AR; Ma JX
Microvasc Res; 2018 Sep; 119():29-37. PubMed ID: 29630973
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting PRMT1 protects against CoNV by regulating macrophages through the FGF2/PI3K/Akt pathway.
Gao Y; Mao J; Zhang R; Deng Q; Wang Y; Pan Y; Liudi S; Wang Y; Fan X; Yang Y; Wan S
Eur J Pharmacol; 2024 May; 977():176673. PubMed ID: 38815785
[TBL] [Abstract][Full Text] [Related]
6. Retraction: Inhibited corneal neovascularization in rabbits following corneal alkali burn by double-target interference for VEGF and HIF-1α.
Biosci Rep; 2024 Jun; 44(6):. PubMed ID: 38818949
[No Abstract] [Full Text] [Related]
7. Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
Behjati S; Tarpey PS; Sheldon H; Martincorena I; Van Loo P; Gundem G; Wedge DC; Ramakrishna M; Cooke SL; Pillay N; Vollan HKM; Papaemmanuil E; Koss H; Bunney TD; Hardy C; Joseph OR; Martin S; Mudie L; Butler A; Teague JW; Patil M; Steers G; Cao Y; Gumbs C; Ingram D; Lazar AJ; Little L; Mahadeshwar H; Protopopov A; Al Sannaa GA; Seth S; Song X; Tang J; Zhang J; Ravi V; Torres KE; Khatri B; Halai D; Roxanis I; Baumhoer D; Tirabosco R; Amary MF; Boshoff C; McDermott U; Katan M; Stratton MR; Futreal PA; Flanagan AM; Harris A; Campbell PJ
Nat Genet; 2014 Apr; 46(4):376-379. PubMed ID: 24633157
[TBL] [Abstract][Full Text] [Related]
8. Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway.
Xueying Z; Liang G; Siyi L; Fengyue LI; Mingli L; Wanting L; Chun M; Guanghui L
J Tradit Chin Med; 2024 Apr; 44(2):268-276. PubMed ID: 38504533
[TBL] [Abstract][Full Text] [Related]
9. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.
Shen M; Zhou XZ; Ye L; Yuan Q; Shi C; Zhu PW; Jiang N; Ma MY; Yang QC; Shao Y
Int J Mol Med; 2018 Aug; 42(2):769-778. PubMed ID: 29717775
[TBL] [Abstract][Full Text] [Related]
10. Daphnetin inhibits corneal inflammation and neovascularization on a mouse model of corneal alkali burn.
Yang T; Wang X; Guo L; Zheng F; Meng C; Zheng Y; Liu G
Int Immunopharmacol; 2022 Feb; 103():108434. PubMed ID: 34920334
[TBL] [Abstract][Full Text] [Related]
11. The role of pirfenidone in alkali burn rat cornea.
Jiang N; Ma M; Li Y; Su T; Zhou XZ; Ye L; Yuan Q; Zhu P; Min Y; Shi W; Xu X; Lv J; Shao Y
Int Immunopharmacol; 2018 Nov; 64():78-85. PubMed ID: 30153530
[TBL] [Abstract][Full Text] [Related]
12. Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats.
Lan C; Liu G; Huang L; Wang X; Tan J; Wang Y; Fan N; Zhu Y; Yu M; Liu X
Invest Ophthalmol Vis Sci; 2022 Apr; 63(4):14. PubMed ID: 35446346
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.
Zhou SY; Xie ZL; Xiao O; Yang XR; Heng BC; Sato Y
Mol Vis; 2010 Jul; 16():1389-98. PubMed ID: 20680097
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
